Drug Available for Australian Meso Victims by New Year
Posted on December 31st, 2007 in Mesothelioma News |
Mesothelioma sufferers from Australia will be able to have the drug Alimta at a low cost after it legally becomes a medicine financed by the country’s government. It will be available under the Pharmaceutical Benefits Scheme (BPS) list by the 1st day of the New Year. It was known to be the sole medicine prescribed for this type of cancer attacking the lungs or stomach linings.
Bernie Bantom was the drug’s advocate whose life was taken away by Mesothelioma last November at the age of 61. His tireless efforts will never go unnoticed and people will definitely appreciate the importance of his campaign for the drug.
There are around 600 Australians every year who are believed to have Mesothelioma. Medical studies show that come year 2020 there will be a close to 18,000 people affected by the disease and usually takes the lives of its people affected by it in a year after a person is concluded to have it.
The drug Alimta will actually be of great help to those with Mesothelioma as it will aid them in battling with the disease and increase their chances of living longer, at the same time having the drug on the BPS list will make it even more suitable for the budget of the common public affected by this aggressive cancer.